Athira Pharma regains Nasdaq compliance after meeting minimum bid requirement
PositiveFinancial Markets

Athira Pharma has successfully regained compliance with Nasdaq by meeting the minimum bid requirement, a significant milestone for the company. This achievement not only stabilizes its market position but also boosts investor confidence, paving the way for future growth and innovation in their pharmaceutical developments.
— Curated by the World Pulse Now AI Editorial System